Neuronascent, Inc.
Neuronascent has discovered and is developing novel, noninvasive “neurorestorative” therapeutics for Alzheimer's and other CNS disorders
- Stage Product In Development
- Industry Biotechnology
- Location Clarksville, MD, USA
- Currency USD
- Founded May 2004
- Employees 2
- Website neuronascent.com
Company Summary
Neuronascent (NNI), founded by Dr. Kelleher-Andersson began operations in 2005. Through NNI's phenotypic screening platform agents were identified that promote mature new neurons. Patents covering NNI's oral therapies are issued. NNI-362, an Alzheimer's candidate has shown reversal of cognitive deficits correlating to increased new neurons in animal models. NNI aims to quickly complete FDA-mandated safety studies with continued support of NIA.
Team
-
Judith Kelleher-AnderssonPresident, CSO
-
Kathleen MattisCFO and Secretary
Advisors
-
Cooley Godward Kronish (bus dev), Wilmer Hale (patent)LawyerUnconfirmedn/aAccountantUnconfirmed
Previous Investors
-
Jefferson Corner GroupUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.